Downloaded from http://veterinaryrecord.bmj.com/ on June 15, 2015 - Published by group.bmj.com
News & Reports RESEARCH
Construction of avian diseases laboratory gets underway at Pirbright A CONCRETE pouring ceremony on July 8 marked the start of the second phase of the redevelopment of the Pirbright Institute in Surrey. New medium containment laboratories are being constructed to house the institute’s avian viral disease research programme, which is currently located on its Compton laboratory site in Berkshire. The £250 million redevelopment of the Pirbright site is being funded by the UK Government through the Biotechnology and Biological Sciences Research Council. The institute’s Compton laboratory is scheduled to close in 2016 and the new 3500 m2 laboratory facility at Pirbright will be used to research viral diseases affecting poultry, such as Marek’s disease, infectious bronchitis virus and avian influenza, as well as low pathogenic viral diseases of other farm animals. The Containment Level 2 (CL2) laboratories are budgeted to cost £15.4 million and will support up to 90 scientists. ‘The building of the CL2 laboratory is critical to delivering the institute’s one site science strategy, allowing our avian viral diseases programme to move from Compton to Pirbright,’ said Michael Johnson, the Pirbright Institute’s head of estates. ‘We are confident that we will deliver an excellent facility that will retain and attract the world’s leading scientists.’ John Fazakerley, director of the Pirbright Institute, added: ‘This second phase of
60 | Veterinary Record | July 19, 2014
Contractors and institute staff at the concrete pouring ceremony for the new medium containment laboratories that are now under construction at Pirbright
redevelopment will enable us to build on previous research and innovation successes in avian viral diseases, such as vaccines against Marek’s disease and the elimination of avian leukosis virus from poultry breeding stock. We will be able to expand our research into these and other important diseases of poultry as well as looking into diseases that
can spread from poultry to humans, such as avian influenza virus.’ The CL2 laboratories will join the new high biocontainment laboratory complex on the Pirbright site. This is currently being evaluated and the institute hopes it will become operational later this year. doi: 10.1136/vr.g4624
Downloaded from http://veterinaryrecord.bmj.com/ on June 15, 2015 - Published by group.bmj.com
Construction of avian diseases laboratory gets underway at Pirbright Veterinary Record 2014 175: 60
doi: 10.1136/vr.g4624 Updated information and services can be found at: http://veterinaryrecord.bmj.com/content/175/3/60.1
These include:
Email alerting service
Receive free email alerts when new articles cite this article. Sign up in the box at the top right corner of the online article.
Notes
To request permissions go to: http://group.bmj.com/group/rights-licensing/permissions To order reprints go to: http://journals.bmj.com/cgi/reprintform To subscribe to BMJ go to: http://group.bmj.com/subscribe/
News & Reports RESEARCH
Construction of avian diseases laboratory gets underway at Pirbright A CONCRETE pouring ceremony on July 8 marked the start of the second phase of the redevelopment of the Pirbright Institute in Surrey. New medium containment laboratories are being constructed to house the institute’s avian viral disease research programme, which is currently located on its Compton laboratory site in Berkshire. The £250 million redevelopment of the Pirbright site is being funded by the UK Government through the Biotechnology and Biological Sciences Research Council. The institute’s Compton laboratory is scheduled to close in 2016 and the new 3500 m2 laboratory facility at Pirbright will be used to research viral diseases affecting poultry, such as Marek’s disease, infectious bronchitis virus and avian influenza, as well as low pathogenic viral diseases of other farm animals. The Containment Level 2 (CL2) laboratories are budgeted to cost £15.4 million and will support up to 90 scientists. ‘The building of the CL2 laboratory is critical to delivering the institute’s one site science strategy, allowing our avian viral diseases programme to move from Compton to Pirbright,’ said Michael Johnson, the Pirbright Institute’s head of estates. ‘We are confident that we will deliver an excellent facility that will retain and attract the world’s leading scientists.’ John Fazakerley, director of the Pirbright Institute, added: ‘This second phase of
60 | Veterinary Record | July 19, 2014
Contractors and institute staff at the concrete pouring ceremony for the new medium containment laboratories that are now under construction at Pirbright
redevelopment will enable us to build on previous research and innovation successes in avian viral diseases, such as vaccines against Marek’s disease and the elimination of avian leukosis virus from poultry breeding stock. We will be able to expand our research into these and other important diseases of poultry as well as looking into diseases that
can spread from poultry to humans, such as avian influenza virus.’ The CL2 laboratories will join the new high biocontainment laboratory complex on the Pirbright site. This is currently being evaluated and the institute hopes it will become operational later this year. doi: 10.1136/vr.g4624
Downloaded from http://veterinaryrecord.bmj.com/ on June 15, 2015 - Published by group.bmj.com
Construction of avian diseases laboratory gets underway at Pirbright Veterinary Record 2014 175: 60
doi: 10.1136/vr.g4624 Updated information and services can be found at: http://veterinaryrecord.bmj.com/content/175/3/60.1
These include:
Email alerting service
Receive free email alerts when new articles cite this article. Sign up in the box at the top right corner of the online article.
Notes
To request permissions go to: http://group.bmj.com/group/rights-licensing/permissions To order reprints go to: http://journals.bmj.com/cgi/reprintform To subscribe to BMJ go to: http://group.bmj.com/subscribe/
